Mark Wiseman · Canadian Ambassador to the United States, Global Affairs Canada (GAC)
Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors.Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and opportunities for investment.
Julie Harb · Policy Advisor to the Prime Minister, Prime Minister's Office (PMO)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and opportunities for investment.Read more
Manuela Tomic · Senior Policy Advisor, Office of the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and opportunities for investment.Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and opportunities for investment.Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Manuela Tomic · Senior Policy Advisor, Office of the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Nasser Haidar · Senior Policy Advisor, Office of the Minister responsible for Canada-U.S. Trade, One Canadian Economy, and Intergovernmental Affairs, Intergovernmental Affairs Secretariat (IGA)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Ali Ehsassi · Parliamentary Secretary to the President of the King’s Privy Council and Minister responsible for Canada-U.S. Trade, Privy Council Office (PCO)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Ritu Banerjee · Assistant Deputy Minister, Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Paul Moen · Chief of Staff to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Ali Ehsassi · Parliamentary Secretary to the President of the King’s Privy Council for Canada and Minister responsible for Canada-U.S. Trade, Intergovernmental Affa, Privy Council Office (PCO)
Maggie Chi · Parliamentary Secretary to the Minister of Health, Health Canada (HC)
Elizabeth Wong · Senior Policy Advisor, Office of the President, Treasury Board Of Canada Secretariat (TBS)
Justine Frame · Policy Advisor, Minister's Office, Health Canada (HC)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Justine Frame · Policy Advisor, Minister's Office, Health Canada (HC)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Manuela Tomic · Senior Policy Advisor, Office of the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Nasser Haidar · Senior Policy Advisor, Office of the Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy, Intergovernmental Affairs Secretariat (IGA)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Justine Frame · Policy Advisor, Minister's Office, Health Canada (HC)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Ian Cameron · Director of Strategy and Senior Advisor, Office of the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Office of the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Ritu Banerjee · Assistant Deputy Minister, Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Policy Branch, Health Canada (HC)
Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors.Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.
Dominic LeBlanc · President of the King’s Privy Council, Minister responsible for Canada-U.S. Trade, Internal Trade, Intergovernmental Affairs and One Canadian Economy, Privy Council Office (PCO)
Karim Bardeesy · Parliamentary Secretary to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Janice Charette · Chief Trade Negotiator to the United States, Privy Council Office (PCO)
and 7 moreShow fewer
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Martin Moen · Associate Assistant Deputy Minister, Trade Policy and Negotiations, Global Affairs Canada (GAC)
Manuela Tomic · Senior Policy Advisor to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Nasser Haidar · Senior Policy Advisor, Privy Council Office (PCO)
Sandenga Yeba · Deputy Chief of Staff & Director of Policy to the Minister, Health Canada (HC)
Justine Frame · Policy Advisor, Minister's Office, Health Canada (HC)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Communicating with government officials about international trade agreements, including the Canada-United States-Mexico Agreement (CUSMA), formerly known as the North American Free Trade Agreement (NAFTA), more specifically as it relates to trade in the life sciences and biopharmaceutical sectors.Read more
Justine Frame · Policy Advisor, Minister's Office, Health Canada (HC)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors.
Martin Moen · Associate Assistant Deputy Minister, Trade Policy and Negotiations, Global Affairs Canada (GAC)
Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors.Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.
Ritu Banerjee · Assistant Deputy Minister, Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.Read more
Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Communicating with government officials about the Government of Canada's "Biomanufacturing and Life Sciences Strategy" (2021).Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.
Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors.
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Special Assistant, Policy, Health Canada (HC)
Communicating with government officials about the Government of Canada's "Biomanufacturing and Life Sciences Strategy" (2021).Read more
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy.
Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors.
Communicating with government officials about the Food and Drugs Act, including about (i) the approval framework for drug products, such as subsequent entry biologics (also known as biosimilars), (ii) export and cross-border trade restrictions for drug products, (iii) data exclusivity for drug products, (iv) approvals (and subsequent reviews) for new drug submissions, and (v) post-market surveillance of drug products.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.